High-Grade Perampanel API – Antagonist for Epilepsy Treatment is a pharmaceutical-grade material with impressive efficacy. Key features include:
Incorporating this product facilitates the development of superior anti-epileptic drugs, contributing significantly to epilepsy management.
Perampanel is an esteemed and high-grade pharmaceutical ingredient that targets seizures associated with epilepsy. It carries an exclusive CAS number 380917-97-5, and its chemical structure is elucidated by the molecular formula C23H15N3O2. Recognized as a powerful non-competitive antagonist of the AMPA receptors, Perampanel has earned its space in the realm of Active Pharmaceutical Ingredients (APIs) used in anti-epileptic drug development.
Key industry-relevant details of Perampanel are:
Marked with its characteristic low molecular weight and distinctive molecular formula, Perampanel operates with a unique Canonical SMILES and IUPAC name. The precise formulation honours the industry's pharmaceutical-grade quality, opening doors for manufacturers to have access to robust ingredients in formulating functional medications.
Perampanel's uniqueness stands in its selective inhibition of the neurotransmitter glutamate's action at the AMPA-type glutamate receptors — a fundamental process in the genesis and propagation of seizures. This property strategically places Perampanel as a valuable API in remedying epilepsy's adverse effects.
This API comes with customizable packaging options to fit your manufacturing constraints, ensuring that your requirements are met with flexibility. Perampanel is compliant with all requisite industrial standards and regulations, so you are assured quality, reliability, and compliance in a packaged deal.
Wrap your operations around the proven quality and effectiveness of Perampanel, an API that has stamped its mark in pharmaceutical environments worldwide. Efficient sourcing, high-grade quality, and personalized packaging come together in Perampanel, a preferred choice in the global medical and pharmaceutical sectors for developing effective antiepileptic treatments.
n